1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Progressive Nonfluent Aphasia: new trials by email Literature Review of Progressive Nonfluent Aphasia trials Research Report on Progressive Nonfluent Aphasia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Davunetide (AL-108) in Predicted Tauopathies - Pilot Study davunetide (AL-108, NAP), Placebo nasal spray - Predicted Tauopathies, Including, Progressive Supranuclear Palsy | Phase 1 | Completed | University of California, San Francisco | 12 | 2010-01-01 | 2019-04-05 |
Corticobasal Degeneration (1) · Frontotemporal Dementia (1) · Frontotemporal Lobar Degeneration (1) · Primary Progressive Nonfluent Aphasia (1) · Supranuclear Palsy, Progressive (1)
Aphasia (1) · Aphasia, Primary Progressive (1) · Basal Ganglia Diseases (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Communication Disorders (1) · Cranial Nerve Diseases (1) · Dementia (1) · Eye Diseases (1) · Language Disorders (1) · Mental Disorders (1) · Metabolic Diseases (1) · Movement Disorders (1) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1)
davunetide (1)
University of California, San Francisco (1)
United States (1)